These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7898455

  • 1. Cellular ADP-ribosylation of elongation factor 2.
    Iglewski WJ.
    Mol Cell Biochem; 1994 Sep; 138(1-2):131-3. PubMed ID: 7898455
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.
    Fendrick JL, Iglewski WJ, Moehring JM, Moehring TJ.
    Eur J Biochem; 1992 Apr 01; 205(1):25-31. PubMed ID: 1313365
    [Abstract] [Full Text] [Related]

  • 3. On the nature of cellular ADP-ribosyltransferase from rat liver specific for elongation factor 2.
    Sayhan O, Ozdemirli M, Nurten R, Bermek E.
    Biochem Biophys Res Commun; 1986 Sep 30; 139(3):1210-4. PubMed ID: 3094526
    [Abstract] [Full Text] [Related]

  • 4. Expression of non-ADP-ribosylatable, diphtheria toxin-resistant elongation factor 2 in Saccharomyces cerevisiae.
    Kimata Y, Harashima S, Kohno K.
    Biochem Biophys Res Commun; 1993 Mar 31; 191(3):1145-51. PubMed ID: 8466491
    [Abstract] [Full Text] [Related]

  • 5. 1-N6-Etheno-ADP-ribosylation of elongation factor-2 by diphtheria toxin.
    Giovane A, Balestrieri C, Quagliuolo L, Servillo L.
    FEBS Lett; 1985 Oct 28; 191(2):191-4. PubMed ID: 2996930
    [Abstract] [Full Text] [Related]

  • 6. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
    Nygård O, Nilsson L.
    Biochim Biophys Acta; 1985 Feb 20; 824(2):152-62. PubMed ID: 3970930
    [Abstract] [Full Text] [Related]

  • 7. Endogenous ADP-ribosylation of elongation factor 2 in polyribosome fraction of rabbit reticulocytes.
    Sitikov AS, Davydova EK, Ovchinnikov LP.
    FEBS Lett; 1984 Oct 15; 176(1):261-3. PubMed ID: 6092136
    [Abstract] [Full Text] [Related]

  • 8. Nucleotide binding to elongation factor 2 inactivated by diphtheria toxin.
    Burns G, Abraham AK, Vedeler A.
    FEBS Lett; 1986 Nov 24; 208(2):217-20. PubMed ID: 3780964
    [Abstract] [Full Text] [Related]

  • 9. Cellular ADP-ribosyltransferase with the same mechanism of action as diphtheria toxin and Pseudomonas toxin A.
    Lee H, Iglewski WJ.
    Proc Natl Acad Sci U S A; 1984 May 24; 81(9):2703-7. PubMed ID: 6326138
    [Abstract] [Full Text] [Related]

  • 10. Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha.
    Morimoto H, Bonavida B.
    J Immunol; 1992 Sep 15; 149(6):2089-94. PubMed ID: 1517572
    [Abstract] [Full Text] [Related]

  • 11. Effect of ADP-ribosylation and phosphorylation on the interaction of elongation factor 2 with guanylic nucleotides.
    Marzouki A, Sontag B, Lavergne JP, Vidonne C, Reboud JP, Reboud AM.
    Biochimie; 1991 Sep 15; 73(7-8):1151-6. PubMed ID: 1742357
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Endogenous ADP-ribosylation of elongation factor 2 in polyoma virus-transformed baby hamster kidney cells.
    Fendrick JL, Iglewski WJ.
    Proc Natl Acad Sci U S A; 1989 Jan 15; 86(2):554-7. PubMed ID: 2536169
    [Abstract] [Full Text] [Related]

  • 14. ADP-ribosylated elongation factor 2 (ADP-ribosyl-EF-2) is unable to promote translocation within the ribosome.
    Davydova EK, Ovchinnikov LP.
    FEBS Lett; 1990 Feb 26; 261(2):350-2. PubMed ID: 2311763
    [Abstract] [Full Text] [Related]

  • 15. Highly frequent single amino acid substitution in mammalian elongation factor 2 (EF-2) results in expression of resistance to EF-2-ADP-ribosylating toxins.
    Kohno K, Uchida T.
    J Biol Chem; 1987 Sep 05; 262(25):12298-305. PubMed ID: 2887567
    [Abstract] [Full Text] [Related]

  • 16. Estimating the amounts of ADP-ribosylatable active elongation factor-2 in mammalian cell-free extracts.
    Riis B, Rattan SI, Clark BF.
    J Biochem Biophys Methods; 1989 Oct 05; 19(4):319-25. PubMed ID: 2693515
    [Abstract] [Full Text] [Related]

  • 17. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
    Bektaş M, Nurten R, Ergen K, Bermek E.
    Cell Biochem Funct; 2006 Oct 05; 24(4):369-80. PubMed ID: 16142694
    [Abstract] [Full Text] [Related]

  • 18. Eukaryotic elongation factor 2 loses its non-specific affinity for RNA and leaves polyribosomes as a result of ADP-ribosylation.
    Sitikov AS, Davydova EK, Bezlepkina TA, Ovchinnikov LP, Spirin AS.
    FEBS Lett; 1984 Oct 29; 176(2):406-10. PubMed ID: 6208057
    [Abstract] [Full Text] [Related]

  • 19. Structure-activity relationships in diphtheria toxin and exotoxin A from Pseudomonas aeruginosa.
    Collier RJ, Gilliland DG, Lory S.
    Prog Clin Biol Res; 1979 Oct 29; 31():751-9. PubMed ID: 119972
    [Abstract] [Full Text] [Related]

  • 20. Utilization of 2'-deoxynad for ADP-ribose transfer reactions.
    Wasson DB, Yamanaka H, Carson DA.
    Adv Exp Med Biol; 1989 Oct 29; 253B():213-8. PubMed ID: 2514587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.